Pharmaceutical Commerce - September/October 2017

The Sharing Conference returns to Baltimore in 2017

The pharma industry has a growing number of dependencies on reliable master data

Global efforts to collect clinical data in a more standardized form will lead to more research innovation

“Cold chain” now means cryogenic and ambient shipping, as well as the traditional 2–8° range

Commission issues interim report with numerous calls to action, while manufacturers and distributors contend with multiple DEA penalties

Supply chain leaders gather in Philadelphia in October

PDUFA reauthorization creates new pathways; GAO report notes FDA’s 99% acceptance rate for expanded access

Global supply chain issues in distribution bring senior execs together

Sales Compensation Solutions, a new book from ZS Associates, outlines problems and solutions

A direct-distribution model could save expense for payers and patients while providing better service

Company is targeting a treatment for glioblastoma; Phase I to begin next year

Pharma needs better internal policies to manage its increasing patient interaction

Observers are critical of the $465-million penalty as too lenient

Is the accelerated-approval process providing a net benefit to patients?

Oncology, obesity control and respiratory therapy are the first targets

New location, following Brexit, will be decided in November